Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of TDF for HIV Prevention in Women
NCT00122486Phase 2Completed
- Sponsor
- FHI 360
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing Tenofovir Disoproxil Fumarate with Placebo (2 arms). Primary endpoints: Conversion for antibodies to HIV 1 or 2 up to 12 months, Serum Creatinine up to 12 months and 4 more. Started Jul 2004; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00122486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00122486.